Chromadex reported Q1 2020 earnings results earlier this week. The following are key quotes from management’s earnings call discussing COVID-19 decimating NAD levels and Nicotinamide Riboside “NR” (FAQs) (Reviews) as a possible solution:

On Plans to Show NR Rescues NAD Supply in Coronavirus

“…there’s been quite a bit of research over the past few months or so that’s published essentially showing the decline of NAD or NAD under attack in coronavirus.

“It’s the same story we’ve been saying as a product since the beginning — NAD comes under attack with age. It comes under attack in this case in a coronavirus infection.

“…that process of the cell defending itself is utilizing NAD and it’s also knocking down the virus — it’s attacking the supply of NAD by knocking down the supply of NAD.

“So it’s very similar to the aging story, it’s just happening in days rather than in years.”

“So…we have to do studies confirming the link between nicotinamide riboside’s (NR) ability to essentially rescue or raise NAD when it’s getting knocked down in that coronavirus cell.”

“…we don’t have to prove that NR can raise any NAD, we KNOW it does that. Multiple human studies have shown that nicotinamide riboside (NR) is safe and multiple studies have shown that nicotinamide riboside (NR) is in fact very much capable of raising NAD levels.”

“What we need to do here in connecting the dots is just showing that in this particular model that we can successfully use nicotinamide riboside (NR) or NIAGEN to rescue NAD supply in coronavirus…..

RELATED:

  • FAQs on taking NAD boosting vitamin supplement Nicotinamide Riboside (NR) can be found HERE.
  • NR supplementation may have helped sufferers of these diseases & conditions (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD